Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
FI: 5,145
Type: Article
Collaboration
Year: 2020
Writers
Casabonne, D; Benavente, Y; Seifert, J; Coasts, L; Armesto, M; Arestin, M; Besson, C; Hosnijeh, F.S.; Duell, EJ; Weiderpass, E; Masala, G; Kaaks, R; Canzian, F; Chirlaque, MD; Perduca, V; Mancini, FR; Shovel, V; Trichopoulou, A; Karakatsani, A; La Vecchia, C;
Magazine
Title: INTERNATIONAL JOURNAL OF CANCER
Quartile
- Q1